SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 9.15 |
| Enterprise Value ($M) | 5.62 |
| Book Value ($M) | -8.66 |
| Book Value / Share | -0.18 |
| Price / Book | -1.06 |
| NCAV ($M) | -9.79 |
| NCAV / Share | -0.21 |
| Price / NCAV | -0.93 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -1.14 |
| Return on Equity (ROE) | -5.84 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.40 |
| Current Ratio | 0.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.05 |
| Assets | 7.19 |
| Liabilities | 15.85 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | 96.03 | |
| 13D/A | Fortress Biotech, Inc. | 7.40 | -88.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 73,405 | 544,922 | 13.47 | |
| 92,969 | 604,566 | 15.38 | |
| 43,221 | 382,783 | 11.29 | |
| 30,319 | 354,333 | 8.56 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LQDA – Liquidia Corporation | LSTA – Lisata Therapeutics, Inc. |
| LTRN – Lantern Pharma Inc. | MBRX – Moleculin Biotech, Inc. |
| ME – 23andMe Holding Co. |
Financial data and stock pages provided by
Fintel.io